Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy Smokers
Interventions
DRUG

V0474 - A mg

Single oral administration

DRUG

V0474 - B mg

Single oral administration

DRUG

V0474 - C mg

Single oral administration

DRUG

V0018 - B mg

Single oral administration

DRUG

Niquitin® Fresh Mint 4 mg

Single oral administration

Trial Locations (1)

Unknown

Eurofins Optimed, Gières

All Listed Sponsors
lead

Pierre Fabre Medicament

INDUSTRY

NCT01574898 - Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations | Biotech Hunter | Biotech Hunter